Ditchcarbon
  • Contact
  1. Organizations
  2. 2seventy bio, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated a month ago

2seventy bio, Inc.

Company website

2seventy bio, Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative cell therapies for cancer treatment. Founded in 2020, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of engineered cell therapies and innovative drug development. With a commitment to advancing the field of oncology, 2seventy bio's core offerings include cutting-edge therapies that harness the power of the immune system to target and eliminate cancer cells. Their unique approach combines scientific expertise with a patient-centric focus, setting them apart in a competitive market. Recognised for its rapid progress and innovative solutions, 2seventy bio is positioned as a leader in the fight against cancer, striving to improve patient outcomes and redefine treatment paradigms.

DitchCarbon Score

How does 2seventy bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

69

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

2seventy bio, Inc.'s score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

83%

Let us know if this data was useful to you

2seventy bio, Inc.'s reported carbon emissions

Inherited from Bristol-Myers Squibb Company

2seventy bio, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bristol-Myers Squibb Company, which influences its climate commitments and emissions reporting. As part of its corporate family, 2seventy bio, Inc. inherits climate initiatives and targets from Bristol-Myers Squibb. This includes commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks. However, specific reduction targets or achievements for 2seventy bio, Inc. have not been disclosed. The absence of direct emissions data suggests that 2seventy bio, Inc. is in the process of establishing its own climate strategy, potentially aligning with the broader goals set by its parent company. The company is expected to contribute to the overarching sustainability efforts of Bristol-Myers Squibb, which may include significant reductions in Scope 1, 2, and 3 emissions as part of their corporate responsibility initiatives. In summary, while 2seventy bio, Inc. does not currently report specific emissions figures or reduction targets, it is positioned within a framework of climate commitments inherited from Bristol-Myers Squibb, indicating a commitment to sustainability and emissions reduction in the future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201520162017201820192020202120222023
Scope 1
210,540,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
150,790,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
69,630,000
00,000,000
00,000,000
00,000,000
000,000,000
00,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. 2seventy bio, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for 2seventy bio, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

2seventy bio, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

TG Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Genmab

DK
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sanofi SA

CH
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Precigen, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy